INDRAMEDCO Intraday Analysis...

INDRAMEDCO Share Price

Open 50.85 Change Price %
High 51.30 1 Day 0.35 0.69
Low 50.30 1 Week 0.20 0.39
Close 51.10 1 Month -0.20 -0.39
Volume 80195 1 Year -0.80 -1.54
52 Week High 64.50
52 Week Low 50.25
INDRAMEDCO Important Levels
Resistance 2 52.03
Resistance 1 51.65
Pivot 50.90
Support 1 50.56
Support 2 50.17
NSE INDIA Most Active Stocks
JPASSOCIAT 18.75 -2.60%
RCOM 13.60 -2.51%
BHEL 92.85 4.74%
HDIL 61.55 0.24%
PRAJIND 105.95 19.99%
SUZLON 13.60 -0.37%
JAICORPLTD 161.05 1.77%
IDEA 96.10 -2.39%
IBREALEST 212.50 -0.26%
PNB 186.50 -1.43%
More..
NSE INDIA Top Gainers Stocks
PRAJIND 105.95 19.99%
MTEDUCARE 68.60 19.93%
APTECHT 395.85 19.45%
PRECOT 101.95 19.03%
SPECIALITY 167.00 17.11%
RAJRAYON 0.35 16.67%
NAGREEKEXP 51.55 16.63%
DIAPOWER 18.45 15.67%
PITTILAM 78.35 15.39%
SIS 1032.15 14.63%
More..
NSE INDIA Top Losers Stocks
KSERASERA 0.15 -25.00%
LCCINFOTEC 0.35 -12.50%
NEULANDLAB 1133.60 -10.75%
PATSPINLTD 32.60 -9.94%
PANORAMUNI 9.35 -9.22%
COMPINFO 26.25 -7.89%
RUCHISOYA 24.75 -6.25%
QUESS 858.00 -6.17%
GLOBALVECT 184.15 -6.02%
LITL 0.80 -5.88%
More..

Indraprastha Medical Corporation Limited (NSE: INDRAMEDCO)

INDRAMEDCO Technical Analysis 5
As on 23rd Nov 2017 INDRAMEDCO Share Price closed @ 51.10 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 54.24 & Strong Sell for SHORT-TERM with Stoploss of 52.30 we also expect STOCK to react on Following IMPORTANT LEVELS.
INDRAMEDCO Target for November
1st Target up-side 53.53
2nd Target up-side 54.64
3rd Target up-side 55.75
1st Target down-side 50.37
2nd Target down-side 49.26
3rd Target down-side 48.15
INDRAMEDCO Synopsis Technicals View
50 Day EMA Close is Below EMA 50 (Short Term)
Bearish
100 Day EMA Close is Below EMA 100 (Mid Term) Bearish
200 Day EMA Close is Below EMA 200 (Long Term) Bearish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is 42.63 Sideways
MFI (14) MFI is 70.62 Sideways
CCI (20) CCI is -91.65 Sideways
WILLIAM %R (14) William %R is Below -80 Over Sold
ADX (14) ADX is 19.06 Range Bound
PSAR Stoploss For Short Sell 54.03
10 Day Avg Volume Traded 6.75 % More then 10 Day Average Volume
INDRAMEDCO Other Details
Segment EQ
Market Capital 1540801536.00
Sector Healthcare
Industry Hospitals
Offical website http://www.apollohospdelhi.com
INDRAMEDCO Address
INDRAMEDCO
Sarita Vihar
Delhi Mathura Road
New Delhi, 110076
India
Phone: 91 11 2692 5858
Fax: 91 11 2682 5563
INDRAMEDCO Latest News
M Ravindran appointed as Chairman of Indraprastha Gas Limited   Jagran Josh   - 10th Feb 15
Financial Results & Limited Review for Dec 31, 2014 (Standalone)   Hindu Business Line   - 29th Jan 15
Congress manifesto for the Delhi Assembly election   The Hindu   - 24th Jan 15
Change in Directorship   Hindu Business Line   - 06th Jan 15
Indraprastha Medical Corp's director MM Kutty resigns   Moneycontrol.com   - 06th Jan 15
Indraprastha Medical Corporation appoints DM Spolia as Chief Secretary   Moneycontrol.com   - 07th Nov 14
ICRA ratings for Indian debt instruments-Sep 22   Reuters   - 22nd Sep 14
Buy Indraprastha Medical; tgt of Rs 51: Firstcall Research   Moneycontrol.com   - 28th May 14
Indraprastha Medical Corporation Limited   Moneycontrol.com   - 28th Jan 14
Indraprastha Medical Corporation appoints SN Sahai as principle secretary   Moneycontrol.com   - 12th Dec 12
Interactive Technical Analysis Chart Indraprastha Medical Corporation Limited ( INDRAMEDCO NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Indraprastha Medical Corporation Limited
INDRAMEDCO Business Profile
Indraprastha Medical Corporation (Indraprastha) is a Delhi-based healthcare company which operates through Indraprastha Apollo Hospital. Indraprastha Apollo, a 695 bed specialty hospital, was commissioned Dec. 1995 in collaboration with New Delhi administration. The hospital spread across an area of 675,000 sq ft is the largest corporate hospital in India and the fourth largest in the world. The hospital has various centers such as Apollo cardiac center, Apollo cancer center, Apollo surgical science center among others. The hospital undertakes activities like health check-ups, transplants, cardiac and other surgeries. The company has operated on around 7.4 million patients. The group also owns 12 hospitals and four clinics. The company posted a sales growth of 17.8% at Rs 584.32 million for quarter ended Sep. 2006, as against Rs 496.07 million for the previous quarter ended September 2005. Net profit increased 3.52% at Rs 17.06 million as against Rs 16.48 million. The company`s net profit for the year ended Mar. 2006 stood at Rs 166.61 million while EPS stood at Rs 1.82. The current market capitalization stands at Rs 327.27 crore. The company has reported a standalone sales of Rs 177.25 crore and a Net Profit of Rs 10.89 crore for the quarter ended September 2013. The company management includes D M Spolia - Chairman, Prathap C Reddy - Vice Chairman, Jaideep Gupta - Managing Director, B Venkataraman - Director, Deepak Vaidya - Director, Ranjit Roy Chaudhury - Director, Renu S Karnad - Director, S C L Das - Director, Satnam Arora - Director, S Regunathan - Director, Shobana Kamineni - Director, Suneeta Reddy - Director, T S Narayanasami - Director, Vijay Lall - Director, V N Rajasekharan Pillai - Director, Archana Arora - Additional Director. The Registered office is at Sarita Vihar, Delhi-Mathura Road, New Delhi, Delhi - 110076.